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A b s t r a c t
Background and aim: The study was undertaken to assess the predictive role of myocardial contractile reserve for functional 
mitral regurgitation (FMR) improvement after cardiac resynchronisation therapy (CRT), and to define other predictors of FMR 
improvement (FMRI) and the impact of FMRI on left ventricular (LV) reverse remodelling.
Methods and results: Among 90 patients in whom echocardiography was performed one day before and six weeks after 
CRT implantation, 66 with at least FMR(2+) in a four-point scale (mean age 64 ± 10 years, mean LV ejection fraction [LVEF] 
25.7 ± 6%, ischaemic aetiology 48%) were included. FMRI was defined as the reduction of the FMR severity by at least one 
grade. The patients were divided into groups: A with FMRI (n = 30) and B without FMRI (n = 36). Contractile reserve was 
evaluated using low-dose dobutamine stress-echo before CRT implantation and was defined as a relative improvement in 
LVEF of more than 20% and segmental contractility improvement. Reverse remodelling was defined as the reduction of the LV 
end-systolic volume (LVESV) by at least 15%. Cox regression multivariate analysis revealed the following predictors for FMRI: 
contractile reserve preserved in more than three segments with an OR = 5.7 (95% CI 1.81–17.97, p = 0.005, sensitivity 65.5%, 
specificity 72.2%, AUC = 0.727) and LV end-diastolic diameter ≤ 74 mm with an OR = 2.09 (95% CI 0.75–5.78, p < 0.05, 
sensitivity 80.0%, specificity 47.2%, AUC = 0.632). FMRI was associated with greater reduction of LVESV (p = 0.002), greater 
increase in LVEF (p < 0.001) and higher incidence of the LV reverse remodelling (p < 0.001).
Conclusions: Preserved contractile reserve and lesser degree of LV dilation were predictive factors of short-term FMR improve-
ment after CRT implantation. FMR improvement was associated with higher incidence of the LV reverse remodelling early, 
already in the six weeks after CRT implantation. 
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INTRODUCTION
Cardiac resynchronisation therapy (CRT) is an established 
treatment option for patients with advanced chronic heart 
failure and prolonged QRS duration. The outcome of CRT is 
determined by a number of factors, and the improvement of 
functional mitral regurgitation (FMR) is one of the mechanisms 
behind the beneficial effect of the treatment [1, 2].
Significant FMR has important prognostic implications and 
is associated with a relatively high morbidity and mortality [3]. 
FMR caused by dilation, altered geometry, and systolic dys-
function of the left ventricle (LV) can itself promote progres-
sive remodelling in the course of ischaemic or non-ischaemic 
dilated cardiomyopathy [4, 5]. This results in a vicious circle, 
with both LV dilatation and FMR acting as self-perpetuating 
processes. CRT may contribute to the reduction of FMR and 
reversing LV dilation [6, 7].
Functional mitral regurgitation, observed in patients 
with ischaemic and non-ischaemic cardiomyopathy, results 
from an imbalance between LV closing forces and mitral 
valve tethering forces, and resultant deformation of mitral 
valve geometry [2, 8]. FMR improvement (FMRI) after CRT 
implantation is a multistage process being modulated by an 
array of factors [2, 9]. The immediate decrease in FMR severity 
is a result of better coordination of ventricular contraction, 
including activation of resynchronised papillary muscles; this 
is reflected by the improvement of systolic function (i.e. the 
closing forces) and reduction of mitral leaflet tethering forces 
[2, 10]. Later reduction of FMR is probably mainly a result of 
the LV reverse remodelling and changes in the geometry of 
mitral apparatus [2, 9]. This latter effect is generally believed 
to develop at mid- and long-term follow-up, i.e. months after 
CRT implantation [2, 6, 7, 9].
It is noteworthy that the outcome of CRT is related to 
myocardial contractile reserve and viability in the paced left 
ventricular region [11]. Myocardial viability can be examined 
with several validated techniques, applied in ischaemic and 
non-ischaemic cardiomyopathy. Contractile reserve as-
sessed by means of a widely available low-dose dobutamine 
stress-echo (LDSE) has high sensitivity and specificity [11–14]. 
Little is known about the predictors of FMRI after CRT 
implantation in short-term observation. While the role of 
preserved contractile reserve as a predictor of post-CRT 
clinical improvement and the LV reverse remodelling is well 
documented, its predictive value with regards to FMRI is 
unclear. The aim of this study was to define the predictors of 
FMRI and to evaluate the impact of FMRI on the incidence 




This study is a sub-analysis of the multicentre Myocardial Via-
bility in Cardiac Resynchronisation Therapy (ViaCRT) trial [14]. 
A total of 90 out of the 129 consecutive patients with is-
chaemic and non-ischaemic LV dysfunction, who underwent 
CRT, were subjected to Doppler echocardiography one day 
prior to CRT implantation and six weeks thereafter. Sixty-six 
out of the 90 patients, presenting with more than mild FMR 
at baseline (FMR ≥ 2+) (mean age 64 ± 10 years, mean LV 
ejection fraction [LVEF] 25.7 ± 6%, ischaemic aetiology 48%) 
were included in this sub-analysis. The inclusion criteria for 
CRT were in line with the current guidelines, i.e. the evidence 
of systolic dysfunction with LVEF ≤ 35% despite optimal 
pharmacotherapy, New York Heart Association (NYHA) class 
II–IV, and QRS duration ≥ 120 ms. Patients with morphological 
abnormalities of the mitral valve, clinical or echocardiographic 
evidence for other structural cardiac diseases, and greater than 
mild aortic regurgitation were excluded.
Clinical assessment 
As well as the echocardiographic evaluation, the clinical status 
of the patients was determined at the baseline and six weeks 
after CRT; the examination included determination of NYHA 
class, medication, and electrocardiogram (ECG) recording.
Echocardiography 
A standard transthoracic echocardiographic examination 
was performed at rest and during LDSE. This included the 
acquisition of optimised grey-scale imaging data sets and 
spectral Doppler flows as well as myocardial velocity data. 
The following parameters were included into the analysis: LV 
internal dimensions in end-diastole (LVEDD) and end-systole 
(LVESD) that were measured from parasternal long-axis view 
two-dimensional (2D) images; LV volumes: LV end-diastolic 
volume (LVEDV), LV end-systolic volume (LVESV), and LVEF 
that were measured using the 2D Simpson method. Dop-
pler myocardial imaging velocity data were recorded using 
a colour-coded technique with two opposing LV walls ad-
justed sector width and optimal depth of imaging in apical 
views. Parameters of dyssynchrony were evaluated at baseline 
and six weeks after CRT implantation. Dyssynchrony was 
defined by tissue Doppler imaging as the maximum differ-
ence of time to onset of systolic velocity for six segments at 
basal level. Inter-ventricular delay (IVD) was calculated as the 
difference between the left ventricular and right ventricular 
pre-ejection periods from pulsed wave Doppler velocity im-
ages of corresponding outflow tracts. LV diastolic filling time 
(DFT) in relation to cardiac cycle length (R-R) was measured 
by transmitral pulsed wave Doppler and expressed as percent-
age of: DFT/R-R.
The severity of FMR was estimated semi-quantitatively 
from colour-flow Doppler images; an integrative approach 
was used, with measurements of vena contracta (VC) and 
mitral regurgitation jet to left atrial area ratio (MR/LA area) 
on a four-point scale on which FMR(1+) corresponded to 
MR/LA area less than 10% and/or VC less than 3 mm, FMR(2+) 
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to MR/LA area between 10% and 20% and/or VC 3 mm, 
FMR(3+) to MR/LA area greater than 20% but no more than 
40% and/or VC greater than 3 mm and no more than 7 mm, 
and FMR(4+) to MR/LA area greater than 40% and/or VC 
greater than 7 mm.
A standard LDSE (up to 20 µg/kg/min) was performed 
prior to CRT implantation. Detailed analysis of segmental 
contractility improvement was conducted. The conventional 
16-segment LV model was used to characterise contraction 
by the wall motion score index (WMSI). Each of the segments 
was analysed individually in multiple echocardiographic views 
on the basis of systolic thickening and motion. The segment 
function was scored as normal = 1, hypokinetic = 2, aki-
netic = 3, or dyskinetic/aneurysmatic = 4. WMSI was calcu-
lated as the sum of all the scores divided by the number of 
visualised segments. More than 20% improvement in WMSI 
(Ø∆WMSI > 20%) or more than 20% improvement in LVEF 
(≠∆LVEF > 20%) from baseline to peak stress was considered 
significant to detect preserved contractile reserve.
Functional mitral regurgitation improvement was defined 
as the reduction of the FMR severity by at least one grade. 
Reverse remodelling was defined as the reduction of 
the LVESV by at least 15% (Ø∆LVESV ≥ 15%). Moreover, the 
LVEF measurements were included into the analysis of the 
CRT effect on myocardial contraction from baseline through 
follow-up.
Statistical analysis 
Normally distributed continuous variables were expressed 
as mean ± standard deviation (SD) unless otherwise indi-
cated. Dichotomous data was expressed as percentages. The 
two-tailed paired and unpaired Student’s t-tests were used 
for intragroup and intergroup comparisons of continuous 
variables, respectively. Categorical data were compared 
using Fisher’s exact test or Pearson’s c2 test. Correlations 
between continuous variables were analysed with a simple 
regression test. Cox regression multivariable analysis model 
was used to identify the independent predictors of FMRI. 
Receiver-operating characteristic (ROC) curves were obtained 
for quantitative variables that differed significantly between 
the two analysed groups, in order to calculate the cutoff val-
ues that most accurately predicted FMRI. The optimal cutoff 
was defined as a value with maximum sum of sensitivity and 
specificity. The results of all the tests were considered signifi-
cant at p-value < 0.05. All the analyses were performed with 
STATISTICA v. 10.0 software.
RESULTS 
Distribution of FMR severity and study groups
Eight out of 90 (9%) patients lacked echocardiographic 
evidence of FMR at the baseline. FMR(1+) was detected 
in 16/90 (18%) patients, FMR(2+) in 26/90 (29%) pa-
tients, FMR(3+) in 29/90 (32%) patients, and FMR(4+) in 
11/90 (12%) patients. Therefore, a total of 24 (27%) patients 
presented with no or mild FMR at the baseline, and 66 pa-
tients showed at least FMR(2+). Severe FMR, corresponding 
to grade (3+/4+), was detected in 40/90 (44%) patients. Six 
weeks after the CRT implantation, the distribution of the FMR 
grades in the subset of patients who presented with at least 
FMR(2+) at baseline was as follows: FMR(1+) 15/90 (17%) pa-
tients, FMR(2+) 21/90 (23%) patients, FMR(3+) 23/90 (26%) 
patients, and FMR(4+) 7/90 (8%) patients. The patients with 
baseline FMR ≥ (2+) were divided into two groups: Group 
A with FMRI (n = 30) and Group B without FMRI (n = 36).
Baseline demographic and clinical characteristics of the 
study groups are presented in Table 1. The groups did not 
differ significantly in terms of age, gender, aetiology (ischaemic 
vs. non-ischaemic), NYHA class, and medication.
Baseline electrocardiographic and echocardiographic 
characteristics of the study groups are presented in Ta-
ble 2. The groups did not differ significantly in terms of QRS 
width. Furthermore, no significant differences in LV volumes, 
LVEF, and site of the latest activation were found. The only 
significant differences pertained to LVEDD and one of dys-
synchrony measures — IVD: patients from Group A were 
characterised by significantly smaller LVEDD (p = 0.041) and 
significantly longer IVD (p = 0.016) than individuals from 
Group B (Table 2).
Difference in the presence of contractile reserve 
between groups 
The incidence of contractile reserve in the study groups is sum-
marised in Table 3. Patients from Group A showed the LDSE 
evidence for contractile reserve significantly more often than 
those from Group B: contractile reserve, defined as a relative 
improvement in LVEF of more than 20% (≠∆LVEF > 20%), 
was detected significantly more often in Group A than in 
Group B (90% vs. 69%, p < 0.05), and the difference in the 
incidence of the relative improvement in WMSI more than 
20% (Ø∆WMSI > 20%) was at the threshold of statistical 
significance (Table 3).
Predictors of FMRI six weeks  
after CRT implantation 
The LDSE evidence for contractility improvement in more than 
three segments (OR = 5.7, 95% CI 1.81–17.97, p = 0.005, 
sensitivity 65.5%, specificity 72.2%, AUC = 0.727) and 
baseline LVEDD ≤ 74 mm (OR = 2.09, 95% CI 0.75–5.78, 
p < 0.05, sensitivity 80.0%, specificity 47.2%, AUC = 0.632) 
were identified as independent predictors of FMRI on Cox 
regression multivariate analysis.
Impact of FMRI on the incidence  
of LV reverse remodelling 
The presence of FMRI six weeks after CRT implantation 
was associated with significantly greater reduction of LVESV 
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10–20% of the patients is probably related to the LV reverse 
remodelling and changes in the geometry of mitral apparatus 
[2, 9]. It is believed that this latter effect appears at mid- and 
long-term follow-up (months) after CRT implantation [2, 6, 9]. 
Di Biase et al. [15] showed that 86% of patients included 
in a prospective registry (n = 398) presented with FMR at 
the time of CRT implantation; 35% of the whole population 
was diagnosed with severe FMR(3+/4+). After 12 months 
of CRT, FMRI by at least one grade was documented in 46% 
of these patients, relatively more often in individuals who 
presented with severe FMR(3+/4+) at baseline (63%) [15]. 
In turn, Cabrera-Bueno et al. [16] recognised significant FMR 
(effective regurgitant orifice area [EROA] ≥ 0.2 cm2) in 43% of 
the 76 patients qualified to CRT; in 34% of them, FMR was 
no longer significant six months after the CRT implantation. 
To the best of our knowledge, our study was the first to as-
sess the incidence of FMRI six weeks after CRT implantation, 
i.e. after a short follow-up. The incidence of FMR at baseline 
was generally similar to that documented in previous studies: 
63% of our patients presented with at least FMR(2+), and 
44% were diagnosed with severe FMR(3+/4+). Six weeks 
(–38 ± 27 mL in Group A vs. –12 ± 36 mL in Group B, 
p = 0.002) and greater increase in LVEF (+10.1 ± 8.5% in 
Group A vs. +2.3 ± 5.5% in Group B, p < 0.001; Table 4). The 
incidence of the LV reverse remodelling defined as the reduc-
tion of the LVESV by at least 15% (Ø∆LVESV ≥ 15%) was signifi-
cantly higher in Group A than in Group B (62.8% vs. 37.2%, 
p < 0.001). The chance to improve Ø∆LVESV ≥ 15% after six 
weeks of CRT in Group A (with FMRI) was 11-fold higher than 
in Group B (without FMRI). Also significantly higher incidence 
of LV reverse remodelling defined as the increase of the LVEF 
by at least 15% (≠∆LVEF ≥ 15%) was demonstrated in Group A 
compared to Group B (76.6% vs. 23.5%, p < 0.01). The 
chance to improve ≠∆LVEF ≥ 15% after six weeks of CRT in 
Group A was six-fold higher than in Group B. 
DISCUSSION
Incidence of FMRI in patients undergoing CRT 
Functional mitral regurgitation is present in a large percentage 
of the population of patients eligible for CRT. Effective CRT 
immediately reduces the transmitral regurgitant volume at rest 
in about 40% of patients [2]. The FMRI observed in a further 
Table 1. Comparison of baseline clinical characteristics between groups
Feature Group A;  
with FMRI (n = 30)
Group B;  
without FMRI (n = 36)
A vs. B
Age [years] pa = 0.263
Mean ± SD 62.1 ± 8.3 64.8 ± 10.7
Median 62.5 64
Min ÷ max 40 ÷ 78 31 ÷ 82
Male gender: 19 (63.3%) 30 (83.3%) pb = 0.064
NYHA functional class: pb = 0.509
Class II 6 (20.7%) 3 (9.1%)
Class III 22 (75.9%) 27 (81.8%)
Class IV 1 (3.4%) 3 (9.1%)
Aetiology (non-ischaemic) 14 (46.7%) 20 (55.6%) pb = 0.637
Previous myocardial infarction 16 (53.3%) 19 (52.8%) pb = 0.839
Hypertension 14 (46.7%) 24 (66.7%) pb = 0.165
Diabetes 8 (26.7%) 12 (33.3%) pb = 0.751
Dyslipidaemia 16 (55.2%) 25 (71.4%) pb = 0.277
Atrial fibrillation 2 (7.4%) 4 (12.9%) pc = 0.404
Medications: 
Beta-blockers 29 (96.7%) 35 (97.2%) pc = 1.000
ACE-I 27 (90%) 29 (80.6%) Pc = 0.327
ARB 2 (6.7%) 4 (11.1%) pc = 0.681
Spironolactone 19 (63.3%) 30 (83.3%) pb = 0.117
Diuretics 25 (83.3%) 33 (91.7%) pc = 0.452
Digoxin 6 (20.0%) 5 (13.9%) pb = 0.740
aUnpaired Student’s t-test; bPearson c2 test; cFisher’s exact test; FMRI — functional mitral regurgitation improvement; SD — standard deviation; 
NYHA — New York Heart Association; ACE-I — angiotensin converting enzyme inhibitors; ARB — angiotensin receptors blockers
www.kardiologiapolska.pl
Predictors of functional mitral regurgitation improvement during a short-term follow-up after CRT
669
Table 2. Comparison of baseline electrocardiographic and echocardiographic parameters between groups (mean ± standard 
deviation) 
Parameter Group A;  
with FMRI (n = 30)
Group B;  
without FMRI (n = 36)
A vs. B
QRS duration [ms] 168 ± 20 160 ± 23 pa = 0.139
LVEDV [mL] 217 ± 30 263 ± 125 pa = 0.074
LVDD [mm] 69 ± 8 74 ± 11 pa = 0.041
LVESV [mL] 158 ± 30 199 ± 107 pa = 0.055
LVSD [mm] 60 ± 8 62 ± 12 pa = 0.309
LVEF [%] 26.5 ± 6.0 24.9 ± 6.0 pa = 0.294
Left atrium [mm] 46.1 ± 10.1 46.4 ± 7.4 pa = 0.925
Left atrium area [cm2] 26.5 ± 8.3 27.8 ± 8.2 pa = 0.554
Interventricular delay [ms] 53 ± 30 33 ± 40 pa = 0.016
Intraventricular dyssynchrony max. (ms] 120 ± 73 96 ± 95 pa = 0.267
Inter- and Intraventricular dyssynchrony (ms] 140 ± 67 119 ± 46 pa = 0.202
DFT/R-R (%] 44.6 ± 10.7 44.0 ± 12.0 pa = 0.856
Site of latest activation: pb = 0.116
Inferolateral wall 15 (51.7%) 11 (33.3%)
Anterior wall 6 (20.7%) 15 (45.5%)
Inferior wall 8 (27.6%) 7 (21.2%)
LVEDV — left ventricular end-diastolic volume; LVEDD — left ventricular end-diastolic dimension; LVESV — left ventricular end-systolic volume; 
LVESD — left ventricular end-systolic dimension; LVEF — left ventricular ejection fraction; DFT/R-R — left ventricular diastolic filling time to cardiac 
cycle length ratio
Table 3. Comparison of the incidence of preserved contractile reserve between the two groups  
Preserved contractile reserve  
in LDSE parameter
Group A; with FMRI;  
6 weeks of CRT (n = 30)
Group B; without FMRI;  
6 weeks of CRT (n = 36)
A vs. B
∆ LVEF > 20% 27 (90%) 25 (69.4%) pc = 0.039
∆ WMSI > 20% 26 (86.7%) 24 (66.7%) pc = 0.053
cFisher’s exact test; LDSE — low-dose dobutamine stress-echo; FMRI — functional mitral regurgitation improvement; CRT — cardiac resynchroni-
sation therapy; LVEF — left ventricular ejection fraction; WMSI — wall motion score index
Table 4. Comparison of the changes of the analysed parameters in both groups six weeks after cardiac resynchronisation therapy 
implantation 
Parameter change Group A;  
with FMRI (n = 30)
Group B;  
without FMRI (n = 36)
A vs. B
∆QRS = QRS6w – QRS0 –22 ± 23 –15 ± 34 p
a = 0.371
∆LVEDV = LVEDV6w – LVEDV0 –29 ± 34 –12 ± 39 p
a = 0.070
∆LVEDD = LVEDD6w – LVEDD0 –4 ± 5 –3 ± 5 p
a = 0.718
∆LVESV = LVESV6w – LVESV0 –38 ± 27 –12 ± 36 p
a = 0.002
∆LVESD = LVESD6w – LVESD0 –5 ± 6 –3 ± 5 p
a = 0.221
∆LVEF = LVEF6W – LVEF0 +10.1 ± 8.5 +2.3 ± 5.5 p
a < 0.001
∆LA area = LA area6W – LA area0 –2.8 ± 3.5 –0.8 ± 5.7 p
a = 0.097
∆IVD = IVD6W – IVD0 –32.1 ± 32.2 –17.3 ± 35.4 p
a = 0.100
∆DFT/R-R (%) = DFT/R-R6W – DFT/R-R0 +6.5 ± 11.6 +2.0 ± 14.6 p
a = 0.175
aUnpaired Student’s t-test; QRS — QRS duration; 6W — six weeks; 0 — baseline; LVEDV — left ventricular end-diastolic volume; LVEDD — left 
ventricular end-diastolic dimension; LVESV — left ventricular end-systolic volume; LVESD — left ventricular end-systolic dimension; LVEF — left 
ventricular ejection fraction; LA — left atrium; IVD — interventricular delay; DFT/R-R — left ventricular diastolic filling time to cardiac cycle length 
ratio
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after the CRT implantation, FMRI by at least one grade was 
documented in one-third of the patients. Our observation 
suggests that the improvement of FMR associated with the 
LV reverse remodelling may occur much earlier than a few 
months after the CRT implantation.
FMRI and the LV reverse remodelling  
after CRT implantation 
Response to CRT may be modulated by the presence of FMR 
prior to the implantation and its persistence despite the treat-
ment. The CARE-HF study revealed that the ‘non-responders’ 
presented with significant FMR more often than the individuals 
who responded to CTR [7]. In turn, Liang et al. [17] found that 
an improvement in pre-existing FMR contributed to LV reverse 
remodelling during a three-month follow-up after CRT implan-
tation. The incidence of the reverse remodelling, expressed 
as LVEF and forward stroke volume improvement, turned out 
to be highest in patients who showed reduction of total FMR, 
intermediate in individuals with mild FMR or lack thereof at 
the baseline, and lowest in persons without improvement in 
total FMR after thee months of post-CRT follow-up [17]. 
Despite a shorter observation period, our findings are 
consistent with the abovementioned data. The patients who 
presented with FMRI six weeks after CRT implantation showed 
evidence for LV reverse remodelling significantly more often 
than those without improvement of FMR. However, we did 
not document corresponding changes in the analysed clini-
cal parameters, i.e. at least one class decrease in the NYHA 
classification. This observation is not surprising for at least 
two reasons: probably too short follow-up period and the 
evidence for rather poor correlation between clinical and 
echocardiographic markers of post-CTR improvement [6]. 
Previous studies showed that clinical response to CTR might 
be observed despite the lack of volumetric changes and vice 
versa [18]. Yu et al. [19] demonstrated that the direction and 
magnitude of the LV reverse remodelling correlate with survival, 
and showed that one-year mortality after CRT is predicted by 
echocardiographic parameters rather than by clinical indices.
Our results suggest that the LV reverse remodelling (re-
lated with the improvement of FMR and probably constituting 
one of the mechanisms for this improvement) occurs much 
earlier than previously thought and despite the lack of clinical 
improvement.  
Dyssynchrony and FMRI  
after CRT implantation 
Agricola et al. [8] demonstrated that the severity of FMR is 
mainly associated with the indices of mitral apparatus defor-
mation; also the regional tissue Doppler-derived dyssynchrony 
index proved to be an independent determinant of EROA in 
their study, but only in patients with non-ischemic LV dysfunc-
tion. In their review paper, Smiseth et al. [20] emphasised the 
fact that the clinical value of many proposed echocardiograph-
ic parameters of the LV dyssynchrony is poorly proven. Many 
of the proposed echocardiographic indices of dyssynchrony 
proved to be inaccurate in a clinical setting due to their poor 
reproducibility and high intra-/interobserver variability [18].
Inter-ventricular delay turned out to be the only base-
line marker of dyssynchrony that distinguished between our 
patients showing FMRI six weeks after CRT implantation 
and those who did not. Stockburger et al. [21] identified LV 
pre-ejection interval and interventricular mechanical delay (an 
equivalent of our IVD) as the predictors of response to CRT, 
namely the LV reverse remodelling. Although the underlying 
mechanisms are not clear, particularly in the case of FMR, 
either the LV pre-ejection interval or IVD prolongation seem 
to be correlated with the degree of left bundle branch block 
— the main determinant of primary electrical dyssynchrony. 
Ypenburg et al. [2] used echocardiographic assessment of 
the baseline latest activation sites to explain detailed mecha-
nisms of early (one-day) and late (six-month) FMRI after CRT 
implantation. The LV dyssynchrony with involvement of 
the posterior papillary muscle resulted in immediate FMR 
changes, whereas the LV dyssynchrony in the lateral wall 
determined late response to the resynchronisation therapy 
[2, 10]. In our six-week observation we did not find any 
relationship between the site of latest activation and FMRI; 
this indicates that mechanisms responsible for improvement 
are more complex.
Inotropic contractile reserve and FMRI 
after CRT implantation 
Myocardial viability and contractile reserve belong to the 
determinants of CRT effectiveness in both ischaemic and 
non-ischaemic cardiomyopathy [11–14]. Lim et al. [11] used 
LDSE to assess contractile reserve, and demonstrated that 
contractile reserve preserved in the paced LV region correlates 
with an acute haemodynamic response and the LV reverse 
remodelling six months after CRT. However, these authors did 
not analyse the relationship between contractile reserve and 
FMRI in response to CRT. 
To the best of our knowledge, the impact of preserved 
contractile reserve on FMRI after CRT implantation has not 
been studied thus far. Our study revealed that the patients 
who showed improvement of FMR six weeks after CRT im-
plantation more often presented with the LDSE evidence for 
contractile reserve at baseline. Moreover, we showed that 
post-CRT improvement of FMR might be expected only if 
the area of contractile reserve documented on baseline LDSE 
was larger than three segments of the LV. The increase in the 
contractility in at least four segments turned out to be an 
independent predictor of FMRI six weeks after CRT implanta-
tion. It should be emphasised that this relationship has been 
demonstrated for at least four of any viable segments because 
it does not analyse the relationship between LV electrode 
location and the location of the viable area. This may suggest 
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a dominant influence of improvement of global rather than 
local remodelling on FMRI after CRT implantation.
Our study was probably the first to evaluate the rela-
tionship between baseline contractile reserve and post-CRT 
improvement of FMR. However, a similar study conducted by 
Senechal et al. [22] should be mentioned; the authors analysed 
the contractile reserve area as a predictor of response to CRT. 
They studied the relationship between the LDSE evidence 
for contractile reserve and FMR prior to CRT implantation 
and acute response to the resynchronisation therapy (defined 
as a relative increase in LV stroke volume more than 15%). 
The average number of viable segments in responders and 
non-responders was 5.8 and 3.9, respectively, and 84% of 
the patients with acute response showed FMRI [22]. The 
co-existence of functional mitral regurgitation and viability in 
the region of the pacing lead turned out to be the most accu-
rate predictor of acute response to CRT [22]. In our study we 
did not analyse the location of viable segments, nevertheless 
there was a relationship between the size of the contractile 
reserve area and the occurrence of FMRI. All these findings 
suggest that the response to CRT can be predicted on the basis 
of concomitantly determined: contractile reserve, incidence 
of FMR, and dynamics of the latter parameter.
Volumetric limitations for FMRI  
after CRT implantation
We showed that the post-CRT improvement in FMR was 
less likely in patients who presented with greater degree of 
LV dilatation. LVEDD less than 74 mm turned out to be the 
independent predictor of FMRI. Diaz-Infante et al. [23] also 
demonstrated a similar size-dependent limit for response to 
CRT. They identified ischaemic heart disease, severe FMR, 
and LV end-diastolic diameter ≥ 75 mm as independent 
predictors of lack of response to CRT. Similarly, Stellbrink 
et al. [24] showed that the non-responders presented with 
significantly higher baseline LVEDV than the patients who 
responded to CRT. 
Both our findings and the results of previous studies sug-
gest that CRT may be insufficient to overcome poor natural 
history of systolic heart failure but may slow down its progres-
sion. The effectiveness of all available therapeutic methods is 
limited, and critically enlarged LV may trigger the previously 
mentioned vicious circle of self-perpetuating LV dilatation and 
functional mitral regurgitation [25].
Limitations of the study
We estimated the severity of FMR semi-quantitatively, by 
currently recommended integrative approach. However, 
according to American Society of Echocardiography and Eu-
ropean Association of Echocardiography (now the European 
Association of Cardiovascular Imaging) the severity of mitral 
regurgitation should be determined on the basis of multiple 
parameters, in order to minimise the bias inherent to each 
individual method, mainly due to their well-known poor 
reproducibility and high intra- and interobserver variability. 
Another potential limitation of our study stems from the fact 
that we did not evaluate the compatibility of the location of 
segments showing preserved contractile reserve with the site 
of LV pacing lead. Despite this we have shown the relation-
ship between the size of contractile reserve area and FMRI.
CONCLUSIONS
1. Preserved contractile reserve and lesser degree of LV 
dilation were predictive factors of short-term FMRI after 
CRT implantation. 
2. FMRI was associated with higher incidence of the LV 
reverse remodelling early — already in the six weeks 
after CRT implantation. 
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S t r e s z c z e n i e
Wstęp i cel: Celem pracy była ocena wartości prognostycznej rezerwy kurczliwości mięśnia sercowego w przewidywaniu poprawy 
czynnościowej niedomykalności zastawki mitralnej (FMR) po wszczepieniu układu resynchronizującego (CRT), a także zdefinio-
wanie innych predyktorów poprawy FMR (FMRI) oraz wpływu FMRI na wystąpienie odwrotnego remodelingu lewej komory. 
Metody i wyniki: Badanie jest subanalizą wieloośrodkowego programu klinicznego The Myocardial Viability in Cardiac Re-
synchronization Therapy (ViaCRT). Spośród 90 pacjentów, u których badanie echokardiograficzne wykonano w dniu poprze-
dzającym wszczepienie układu CRT, a następnie po 6 tygodniach, do analizy włączono 66 osób z FMR co najmniej 2 stopnia 
(FMR[2+]) w 4-stopniowej skali czynnościowej niedomykalności zastawki mitralnej (śr. wiek 64 ± 10, śr. LVEF 25,7 ± 6%, 
etiologia niedokrwienna 48%). FMRI zdefiniowano jako redukcję stopnia ciężkości FMR o co najmniej 1 stopień. Pacjenci 
zostali podzieleni na dwie grupy: grupa A — z FMRI (n = 30) oraz grupa B — bez FMRI (n = 36). Rezerwę kurczliwości oce-
niano za pomocą echokardiograficznej próby dobutaminowej niskiej dawki wykonanej w dobie przed wszczepieniem CRT 
i została ona zdefiniowana jako względna poprawa LVEF powyżej 20% oraz poprawa kurczliwości segmentalnej. Odwrotny 
remodeling zdefiniowano jako względną redukcję końcowoskurczowej objętości lewej komory (LVESV) o co najmniej 15%. 
Wieloczynnikowa analiza regresji Coxa ujawniła następujące predyktory FMRI: zachowana rezerwa kurczliwości w więcej 
niż trzech segmentach komory z ilorazem szans (OR) = 5,7 (95% CI 1,81–17,97; p = 0,005; czułość 65,5%; specyficzność 
72.2%; AUC = 0,727) oraz końcoworozkurczowy wymiar lewej komory ≤ 74 mm z OR =2,09 (95% CI 0,75–5,78; p < 0,05; 
czułość 80,0%; specyficzność 47,2%; AUC = 0,632). FMRI wiązała się z większym stopniem redukcji LVESV (p = 0,002), 
większą poprawą LVEF (p < 0,001) oraz częstszym występowaniem odwrotnego remodelingu (p < 0,001). 
Wnioski: Zachowana rezerwa kurczliwości i mniejszy stopień powiększenia lewej komory były czynnikami prognostycznymi 
wczesnej poprawy FMR po wszczepieniu CRT. Poprawa FMR wiązała się z częstszym występowaniem odwrotnego remode-
lingu lewej komory wcześnie, już w 6. tygodniu po wszczepieniu CRT. 
Słowa kluczowe: terapia resynchronizująca, czynnościowa niedomykalność zastawki mitralnej, echokardiograficzna próba 
dobutaminowa, rezerwa kurczliwości mięśnia sercowego, odwrotny remodeling w niewydolności serca 
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